HeartBeam, Inc.

HeartBeam is a medical technology company that develops innovative, higher resolution ambulatory cardiac monitoring solutions. The company's proprietary and patented technology platform collects the heart's electrical activity from three dimensions and synthesizes a 12-Lead (12L) Electrocardiogram (ECG) from these signals. HeartBeam aims to enable the detection and monitoring of cardiac disease outside of a healthcare facility. The company believes its products and services will benefit patients, healthcare providers, and healthcare payers, and address the rapidly growing field of ambulatory cardiac monitoring. HeartBeam's long-term vision includes playing a central role in high-risk Coronary Artery Disease (CAD) monitoring, supported by initial feasibility studies demonstrating comparable performance of the HeartBeam System and the standard 12L ECG in ischemia detection. The HeartBeam System is the company's initial product and service offering. It is the first U.S. Food and Drug Administration (FDA) cleared cable-free, ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment. The HeartBeam System includes a credit card sized 3D ECG recording device, a patient application, a physician portal, and cloud-based algorithms. Its patented cable-free technology captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a 12L ECG display using a personalized transformation matrix.